Soeteman Djøra I, Resch Stephen C, Jalal Hawre, Dugdale Caitlin M, Penazzato Martina, Weinstein Milton C, Phillips Andrew, Hou Taige, Abrams Elaine J, Dunning Lorna, Newell Marie-Louise, Pei Pamela P, Freedberg Kenneth A, Walensky Rochelle P, Ciaranello Andrea L
Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
MDM Policy Pract. 2020 Jun 12;5(1):2381468320932894. doi: 10.1177/2381468320932894. eCollection 2020 Jan-Jun.
Metamodels can simplify complex health policy models and yield instantaneous results to inform policy decisions. We investigated the predictive validity of linear regression metamodels used to support a real-time decision-making tool that compares infant HIV testing/screening strategies. We developed linear regression metamodels of the Cost-Effectiveness of Preventing AIDS Complications Pediatric (CEPAC-P) microsimulation model used to predict life expectancy and lifetime HIV-related costs/person of two infant HIV testing/screening programs in South Africa. Metamodel performance was assessed with cross-validation and Bland-Altman plots, showing between-method differences in predicted outcomes against their means. Predictive validity was determined by the percentage of simulations in which the metamodels accurately predicted the strategy with the greatest net health benefit (NHB) as projected by the CEPAC-P model. We introduced a zone of indifference and investigated the width needed to produce between-method agreement in 95% of the simulations. We also calculated NHB losses from "wrong" decisions by the metamodel. In cross-validation, linear regression metamodels accurately approximated CEPAC-P-projected outcomes. For life expectancy, Bland-Altman plots showed good agreement between CEPAC-P and the metamodel (within 1.1 life-months difference). For costs, 95% of between-method differences were within $65/person. The metamodels predicted the same optimal strategy as the CEPAC-P model in 87.7% of simulations, increasing to 95% with a zone of indifference of 0.24 life-months ( ∼ 7 days). The losses in health benefits due to "wrong" choices by the metamodel were modest (range: 0.0002-1.1 life-months). For this policy question, linear regression metamodels offered sufficient predictive validity for the optimal testing strategy as compared with the CEPAC-P model. Metamodels can simulate different scenarios in real time, based on sets of input parameters that can be depicted in a widely accessible decision-support tool.
元模型可以简化复杂的卫生政策模型,并能即时得出结果以辅助政策决策。我们研究了用于支持一种比较婴儿HIV检测/筛查策略的实时决策工具的线性回归元模型的预测效度。我们开发了预防艾滋病并发症儿科成本效益(CEPAC-P)微观模拟模型的线性回归元模型,该模型用于预测南非两种婴儿HIV检测/筛查方案的预期寿命以及每人一生与HIV相关的成本。通过交叉验证和布兰德-奥特曼图评估元模型的性能,该图显示了预测结果相对于其均值的方法间差异。预测效度由元模型准确预测出CEPAC-P模型所预计的具有最大净健康效益(NHB)的策略的模拟次数百分比来确定。我们引入了一个无差异区间,并研究了在95%的模拟中产生方法间一致性所需的区间宽度。我们还计算了元模型做出“错误”决策导致的NHB损失。在交叉验证中,线性回归元模型准确地近似了CEPAC-P模型预测的结果。对于预期寿命,布兰德-奥特曼图显示CEPAC-P模型和元模型之间有良好的一致性(差异在1.1个生命月以内)。对于成本,95%的方法间差异在每人65美元以内。元模型在87.7%的模拟中预测出与CEPAC-P模型相同的最优策略,当无差异区间为0.24个生命月(约7天)时,这一比例增至95%。元模型做出“错误”选择导致的健康效益损失较小(范围:从0.0002至1.1个生命月)。对于这个政策问题,与CEPAC-P模型相比,线性回归元模型为最优检测策略提供了足够的预测效度。元模型可以基于一组输入参数实时模拟不同场景,这些输入参数可以在一个广泛可用的决策支持工具中呈现。